Therapeutic uses of goserelin acetate
US6140315A · kind A · utility
2Cited by
3References
3Claims
0Family size
Inventors
Key dates
| Filing date | Jun 5, 1998 |
| Grant date | Oct 31, 2000 |
| Priority date | — |
| Expiry date | Jun 5, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of decreasing atherosclerosis and its complications, such as myocardial infarction, stroke and peripheral vascular disease, wherein the method involves administering to a human or an animal an amount of goserelin acetate sufficient to decrease atherosclerosis and its complications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.